001540.KQ

Equity

AHN-GOOK PHA

Health Care · Drug Manufacturers - Specialty & Generic

$7,280.00

+7,280.00 (+0.00%)

Open

N/A

Day Range

$7,280.00 - $7,820.00

52W Range

$6,230.00 - $9,400.00

Volume

162K

Price History

Key Statistics

Market Cap

N/A

P/E Ratio

N/A

EPS

N/A

Dividend Yield

N/A

P/B Ratio

N/A

Payout Ratio

N/A

ROE

N/A

Debt/Equity

N/A

Institutional Ownership

0.2% Institutional 48.2% Insider 51.6% Public

Latest News

Costco is opening 6 locations in March and April. See the full list

USA TODAY 1 day ago

Cerus: Q4 Earnings Snapshot

Associated Press Finance 1 day ago

ING Comments on Euro, Swiss Franc, Hungary's Forint, Turkey's Lira

MT Newswires 2 days ago

CoreWeave to Participate in Upcoming Morgan Stanley TMT and Cantor Global Technology Investor Conferences

Business Wire 4 days ago

Tidewater Utilities Announces Customer Bill Credit Using PFAS Litigation Proceeds

GlobeNewswire 4 days ago

Peers in Health Care

Symbol Name Price Mkt Cap Div Yield Change
ABBV AbbVie Inc. $233.86 N/A 2.84% +0.00%
CRSP CRISPR Therapeutics AG $58.06 N/A - +0.00%
ACAD ACADIA Pharmaceuticals Inc. $22.50 N/A - +0.00%
AHCO AdaptHealth Corp. $9.40 N/A - +0.00%
A Agilent Technologies, Inc. $119.04 N/A 0.84% +0.00%
ACB Aurora Cannabis Inc. $3.48 N/A - +0.00%
ABCL AbCellera Biologics Inc. $3.71 N/A - +0.00%
ABT Abbott Laboratories $114.12 N/A 2.10% +0.00%

Community Sentiment

Sign in to vote

0% Bullish 0% Neutral 100% Bearish

0 votes

Discussion (0)

Sign in to join the discussion

Loading comments...

About AHN-GOOK PHA

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

www.ahn-gook.com →

🐂 Bull Score

Our proprietary rating measures dividend reliability based on 6 fundamental factors including payout sustainability, financial strength, and cash flow coverage.

F 10/100

Very Risky

Bull Score

~ Growing dividend (9 years) 10/25
- Negative profit margin 0/15
Limited data — score may change as more metrics become available

Dividend Safety

Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.

45

Borderline

Based on 4 fundamental factors

+ 9 years of growth
- Negative profit margin

Analysis Tools

Sign in for analysis tools

Share